Steffen Hauptmann
No ORCID on file
· 1 paper in corpus
review
2017
Borderline ovarian tumors (BOT) are uncommon but not rare epithelial ovarian neoplasms, intermediate between benign and malignant categories. Since BOT were first identified >40 years ago, they have inspired controversies disproportionate t…